Pentacyclic kinase inhibitors

Details for Australian Patent Application No. 2006279659 (hide)

Owner Genentech, Inc. Hoffman-La Roche, Inc.

Inventors Rawson, Thomas E.; Zhu, Bing-Yan; Li, Jun M.; Zhang, Birong; Halladay, Jason; Liang, Jun; Safina, Brian; Rueth, Matthias; Prime, Michael; Brookfield, Frederick; Aliagas-Martin, Ignacio; Dotson, Jennafer

Agent Davies Collison Cave

Pub. Number AU-A-2006279659

PCT Pub. Number WO2007/022102

Priority 60/707,902 12.08.05 US

Filing date 14 August 2006

Wipo publication date 22 February 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/022102 Priority application(s): WO2007/022102

19 February 2009 Alteration of Name

  The name of the applicant has been altered to Genentech, Inc.; F. Hoffmann-La Roche, AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279670-Solid dosage forms of valsartan and amlodipine and method of making the same

2006279658-Treatment of diseases by subcutaneous administration of a VEGF antagonist